CATALYST PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - SECTION 906 PEO CERTIFICATION - August 15, 2011

Attached files

file filename
10-Q - FORM 10-Q - CATALYST PHARMACEUTICALS, INC.d10q.htm
EXCEL - IDEA: XBRL DOCUMENT - CATALYST PHARMACEUTICALS, INC.Financial_Report.xls
EX-10.1 - FIRST AMENDMENT TO LEASE - CATALYST PHARMACEUTICALS, INC.dex101.htm
EX-32.2 - SECTION 906 PFO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.dex322.htm
EX-31.2 - SECTION 302 PFO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - SECTION 302 PEO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.dex311.htm

Exhibit 32.1

Certification Required by 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

I, Patrick J. McEnany as Principal Executive Officer of Catalyst Pharmaceutical Partners, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

 

1. the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2011 (the “Report”), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 15, 2011  

/s/ Patrick J. McEnany

  Patrick J. McEnany
  Chief Executive Officer
  (Principal Executive Officer)

Stock widget

Investing forum

CATALYST PHARMACEUTICALS, INC. Reports

Also read